Refined mapping of loss of heterozygosity in Chinese sporadic gastric carcinoma

African Journal of Biotechnology

Volumn 9, Issue 35, 2010, Pages 5754-5761

  Wang, Quan ^a   Wen, Yu Gang ^a   Li, Da Peng ^a   Huang, Fei ^a   Zhou, Chong Zhi ^a   Qiu, Guo Qiang ^a   Tang, Hua Mei ^a   Peng, Zhi Hai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gastric carcinoma; Loss of heterozygosity (LOH); Refined mapping; Tumor markers; Tumor suppressor genes (TSGs)

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CHINESE; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 18P; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 22Q; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 6P; CHROMOSOME 9Q; CLINICAL ARTICLE; CLINICAL CLASSIFICATION; COMPUTER PROGRAM; CONTROLLED STUDY; DISTANT METASTASIS; DNA SEQUENCE; FEMALE; GEL ELECTROPHORESIS; GENE DELETION; GENE LOCUS; GENE MAPPING; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LAUREN TYPE; LYMPH NODE METASTASIS; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; SPORADIC GASTRIC CARCINOMA; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 77957369889     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ariza M, Llorente JL, Alvarez-Marcas C, Baragaño L, Salas A, Rodriguez Prado N, Hermsen M, Suárez C, Sampedro A. (2004).Comparative genomic hybridization in primary sinonasal adenocarcinomas.Cancer 100: 335-341,2004.
2. Bae SC, Takahashi E, Zhang YW, Ogawa E, Shigesada K, Namba Y, Satake M, Ito Y. (1995). Cloning, mapping and expression of PEBP2- alpha-C, a third gene encoding the mammalian Runt domain. Gene 159: 245-248.
3. Chae KS, Ryu BK, Lee MG, Byun DS, Chi SG. (2002). Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma. Eur J Cancer 38: 2048-2057.
4. Chanudet E, Ye H, Ferry J, Bacon CM, Adam P, Müller-Hermelink HK, Radford J, Pileri SA, Ichimura K, Collins VP, Hamoudi RA, Nicholson AG, Wotherspoon AC, Isaacson PG, Du MQ. (2009). VPA20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.J Pathol 217: 420-430.
5. Chong JM, Fukayama M, Hayashi Y, Takizawa T, Koike M, Konishi M, Kikuchi-Yanoshita R, Miyaki M. (1994). Microsatellite instability in the progression of gastric carcinoma. Cancer Res 54: 4595-4597.
6. Dai YC, Ho CL, Tsai YC, Hsu YH, Chang YC, Liu HS, Chen HH, Chow NH. (2003). Allelic loss of 14q32 in the pathogenesis of gastrointestinal and ampullary malignancies: mapping of the target region to a 17 cM interval.J Cancer Res Clin Oncol 131: 94-100.
7. De Manzoni G, Tomezzoli A, Di Leo A, Moore PS, Talamini G, Scarpa A. (2001). Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer.Br J Surg 88: 419-425.
8. Dimova I, Orsetti B, Negre V, Rouge C, Ursule L, Lasorsa L, Dimitrov R, Doganov N, Toncheva D, Theillet C. (2009). Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis.Tumori 95: 357-66.
9. Fiocca R, Luinetti O, Villani L, Mastracci L, Quilici P, Grillo F, Ranzani GN. (2001). Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype. Hepatogastroenterology 48: 1523-1530
10. Friedrich K, Weber T, Scheithauer J, Meyer W, Haroske G, Kunze KD, Baretton G. (2008). Chromosomal genotype in breast cancer progression: comparison of primary and secondary manifestations.Cell Oncol 30: 39-50.
11. Grundei T, Vogelsang H, Ott K, Mueller J, Scholz M, Becker K, Fink U, Siewert JR, Höfler H, Keller G. (2000). Loss of heterozygosity and microsatellite instability as predictive markers for neoadjuvant treatment in gastric carcinoma. Clin Cancer Res 6: 4782-4788.
12. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ.(2005).Cancer statistics,2005. CA Cancer J Clin 55: 10-30.
13. Jiao YF, Sugai T, Habano W, Uesugi N, Takagane A, Nakamura S. (2006). Clinicopathological significance of loss of heterozygosity in intestinal- and solid-type gastric carcinomas: a comprehensive study using the crypt isolation technique.Mod Pathol 19: 548-555.
14. Kaneda A, Wakazono K, Tsukamoto T, Watanabe N, Yagi Y, Tatematsu M, Kaminishi M, Sugimura T, Ushijima T. (2004). Lysyloxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 64: 6410-6415.
15. Kang JU, Kang JJ, Kwon KC, Park JW, Jeong TE, Noh SM, Koo SH. (2006). Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization.J Korean Med Sci 21: 656-665.
16. Katoh M.(2002). Structure and expression of Strabismus 1 gene on human chromosome 1q21-q23.Int J Oncol 20: 1197-203.
17. Katoh M and Katoh.(2003). MIdentification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico.Int J Oncol 22: 1161-1168.
18. Knudson A (1971). Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68: 820-823.
19. Kobayashi M, Ishida H, Shindo T, Niwa S, Kino M, Kawamura K, Kamiya N, Imamoto T, Suzuki H, Hirokawa Y, Shiraishi T, Tanizawa T, Nakatani Y, Ichikawa T. (2008). Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.Prostate 68: 1715-1724.
20. Koon N, Zaika A, Moskaluk CA, Frierson HF, Knuutila S, Powell SM, El-Rifai W. (2004).Clustering of molecular alterations in gastroesophageal carcinomas. Neoplasia 6: 143-149.
21. Monpezat JP, Delattre O, Bernard A, Grunwald D, Remvikos Y, Muleris M, Salmon RJ, Frelat G, Dutrillaux B, Thomas G. (1988). Loss of alleles on chromosome 18 and on the short arm of chromosome 17 in polyploid colorectal carcinomas. Int J Cancer 41: 404-408.
22. Nishizuka S, Tamura G, Terashima M, Satodate R. (1998). Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach.J Pathol 185: 38-43.
23. Nowacka-Zawisza M, Bryś M, Romanowicz-Makowska H, Kulig A, Krajewska WM. (2008). Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.Cancer Detect Prev 32: 144-148.
24. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Tomlinson IP, Taylor M, Greaves M, Houlston RS. (2009). Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.Nat Genet. 41: 1006-1010.
25. Prazeres HJ, Rodrigues F, Soares P, Naidenov P, Figueiredo P, Campos B, Lacerda M, Martins TC. (2008). Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma.Fam Cancer 7: 141-149.
26. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G, Tahara E. (1991). Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinoma. Cancer Res 51: 2926-2931.
27. Semba S, Yokozaki H, Yamamoto S, Yasui W, Tahara E (1996). Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 77: 1620-1627.
28. Semba S, Yokozaki H, Yasui W, Tahara E. (1998). Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1(17q21) in young patients with gastric cancer. Int J Oncol 12: 1245-1251.
29. Stephen RL, Crabtree JE, Yoshimura T, Clayton CL, Dixon MF, Robinson PA. (2003). Increased zinc finger protein zFOC1 transcripts in gastric cancer compared with normal gastric tissue.Mol Pathol 56: 167-171.
30. Takahata M, Inoue Y, Tsuda H, Imoto I, Koinuma D, Hayashi M, Ichikura T, Yamori T, Nagasaki K, Yoshida M, Matsuoka M, Morishita K, Yuki K, Hanyu A, Miyazawa K, Inazawa J, Miyazono K, Imamura T. (2009). SKI and MEL1 cooperate to inhibit transforming growth factorbeta signal in gastric cancer cells.J Biol Chem. 284: 3334-3344.
31. Tokumaru Y, Nomoto S, Jerónimo C, Henrique R, Harden S, Trink B, Sidransky D. (2003). Biallelic inactivation of the RIZ1 gene in human gastric cancer.Oncogene 22: 6954-6958.
32. Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, Frierson H Jr, Powell SM, Knuutila S, Kallioniemi A, El-Rifai W. (2002). Targets of gene amplification and overexpression at 17q in gastric cancer.Cancer Res 62: 2625-2629.
33. Vauhkonen H, Vauhkonen M, Sajantila A, Sipponen P, Knuutila S. (2006). DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization.Cancer Genet Cytogenet 167: 150-154.
34. Wang GS, Wang MW, Wu BY, You WD, Yang XY. (2003). A novel gene, GCRG224, is differentially expressed in human gastric mucosa.World J Gastroenterol.9: 30-34.
35. Wang X, Lau KK, So LK, Lam YW. (2009). CHD5 is down-regulated through promoter hypermethylation in gastric cancer.J Biomed Sci 16: 95.
36. Xu S, Han JC, Morales A, Menzie CM, Williams K, Fan YS. (2008). Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism.Cytogenet Genome Res 122: 181-187.
37. Yu J, Zhou H, Jin Y, Bai J, Yu Y, Geng J, Qi J, Fu S. (2008). Three distinct regions of allelic deletion on chromosome 17 involved in sporadic gastric cancer.Hepatogastroenterology 55: 1487-1491.
38. Zhou CZ, Qiu GQ, Fan JW, Wang XL, Tang HM, Huang L, Sun YH, Peng ZH. (2008). Refined mapping of loss of heterozygosity on 1q31.1-32.1 in sporadic colorectal carcinoma. World J Gastroenterol 14: 1582-1587.